PXL/HO/Cir-013/2021-22                                                                                         Date: 13.05.2021

Hyderabad

Dear Sir/Madam,

Subject: Investment proposal by M/s. Terragene, an Argentine biotechnological company

Pharmexcil is in receipt of communication from Embassy of India, Argentina wherein M/s. Terragene, an Argentine biotechnological company plans to set up operations in India & intends to find new partners for enlarging their distribution network.

M/s.Terragene engaged in developing innovative biotechnological solutions over a wide range of biological and chemical indicators for monitoring different sterilization, washing, cleaning and disinfection processes & is currently reinforcing its market presence by making direct investment in key countries including  India as a part of their expansion strategy.

The Argentine company intends to find new partners for enlarging their distribution network and build a local team wherein they can offer a strategic and clear understanding of the Indian market which would help the company in reduction of logistic costs, optimization of delivery process and improvement of the management distribution and sales channels. A brief note on their current business operations and their plans to set up operations in India is enclosed herewith for your ready reference.

Interested member companies are advised to take advantage of this partnership opportunity and may like to contact Mr. Nicolas Creus, Director of International Business at nicolas.creus@terragene.com for detailed information.

With regards

Uday Bhaskar

Director General

ENCL: Terragene Project – India

Disclaimer:

Members may please note that the above information is circulated on the basis of information received from M/s. Terragene, Argentina, through Embassy of India, Argentina. Members are advised to make their own decisions before finalizing their business transactions.